Ascendis Pharma A/S (NASDAQ:ASND) Q1 2026 Earnings Call Transcript May 7, 2026
Ascendis Pharma A/S beats earnings expectations. Reported EPS is $0.32, expectations were $0.21.
Operator: Good day, and thank you for standing by. Welcome to the First Quarter Ascendis Pharma Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your first speaker today, Chad Fugure, Vice President of Investor...
